Iproniazid

DB04818ApprovedWithdrawnSmall molecule

Withdrawn from the Canadian market in July 1964 due to interactions with food products containing tyrosine.

Chemical structure of Iproniazid
Mechanism
Curator reviewed
Primary indication
For the treatment of depression (originally intended to treat tuberculosis).Curator reviewed
Formula / weight
C9H13N3O · 179.219 g/mol (avg)
Code names
P 887 · Ro 2-4572

Resolves to

Compound
UNIID892HFI3XACAS54-92-2ChEMBLCHEMBL92401ChEBI5958PubChem3748KEGGD02579
Clinical / RWD
RxNorm5981ATCN06AF05
Structure
InChIKeyNYMGNSNKLVNMIA-UHFFFAOYSA-NSMILESCC(C)NNC(=O)C1=CC=NC=C1
Targets
P27338MAOBP21397MAOA

What you can answer from here — as of October 01, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
1,768Drug interactionsStructured to mechanism, not free text
Sign in
1ATC codeIncluding every combination product, plus 23 drug categories
Sign in
15+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Iproniazid, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In